Rigel Pharmaceuticals, Inc. (RIGL)

34.66 -0.08 (-0.23%) USD  |  NASDAQ  |  Mar 02, 13:11
More

Rigel Pharmaceuticals Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for RIGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Nektar Therapeutics Upgrade
Eli Lilly & Co. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade